Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia
- Conditions
- NeoplasmsPediatric CancerPhysical TherapyTelemedicine
- Interventions
- Behavioral: Physical Therapy
- Registration Number
- NCT06170385
- Lead Sponsor
- University of Alberta
- Brief Summary
The purpose of this study is to determine the feasibility and acceptability of a hybrid in-person and virtual individualized physiotherapy program using the Healthy Eating and Active Living (HEAL-ME) online platform for children diagnosed with acute lymphoblastic leukemia. We would like to know if this type of hybrid program delivery model is feasible, and if children and their parents are willing and able to participate in the program. We will do this by recording how many, and what type of physiotherapy sessions (in-person or virtual) are completed, what resources offered on the platform are accessed, and how many children complete the assessments.
- Detailed Description
Acute lymphoblastic leukemia is the most common childhood cancer, representing approximately 25% of cancers in children. Improvements in survival rates have resulted in an increased number of children living with neuromuscular and musculoskeletal side effects of cancer treatments-effects that may persist or worsen over the long-term into adulthood.
The overall goal of the study is to determine the feasibility of a tailored physiotherapy (PT) program using an online platform for children diagnosed with acute lymphoblastic leukemia.
A quasi-experimental, single group, before and after intervention feasibility study will be conducted, comprising a convenience sample of a minimum of 10 children between 4 and 17 years of age undergoing or having completed chemotherapy treatment for acute lymphoblastic leukemia. Children will participate in a hybrid 12-week PT program delivered in-person at the Stollery Children's Hospital with educational components provided virtually via the Healthy Eating and Active Living web-based platform. Children will participate in six physical therapy sessions over a period of three months and will have the option to choose the mode of delivery: 1:1 in-person, 1:1 virtual, group virtual, or combination of all. The main outcome will be feasibility, as determined by recruitment and retention rates, completion rates of measurements, adherence to sessions, and safety and acceptability.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 10
- Children diagnosed with acute lymphoblastic leukemia aged between 4 and 17 years (at time of diagnosis) and their mother, father, or primary carer;
- Undergoing or completed cancer treatment as established by the Children's Oncology Group;
- Access to the internet through a home computer or tablet;
- Patient or caregiver is able to speak and comprehend English; and
- The child is approved by their Oncologist to participate in the program.
- Children with a history of a neurodevelopmental or genetic disorder (i.e., Down syndrome, autism, seizure disorder) prior to the cancer diagnosis; and
- Children with a concurrent condition (illness, disease, psychiatric disorder), as determined by oncologist or physiotherapist, that would compromise study participation or interpretation of study results.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Intervention Physical Therapy Children will participate in six PT sessions over the course of 12 weeks and will be provided with the option to choose their preferred mode of the delivery (i.e., 1:1 in-person, 1:1 virtual, group virtual, or a combination of all). The program will be tailored to the child's age, presenting symptoms, and preferred activities. Children and parents/ caregivers will be encouraged to carry out additional tailored PT sessions through their preferred mode of delivery and to access the exercise videos provided in the additional resources section of the HEAL-ME platform.
- Primary Outcome Measures
Name Time Method Retention rate Post-intervention: 12 weeks The number of participants completing the intervention and assessments
- Secondary Outcome Measures
Name Time Method Adverse events One year Number of serious and non-serious adverse events
Adherence to study intervention Post-intervention: 12 weeks Attendance rates for in-person and virtual physical therapy sessions
Health-related Quality of Life Post-intervention: 12 weeks Pediatric Quality of Life Inventory Version 4: Total scale score, with higher scores reflecting better quality of life
Recruitment rate One year Number eligible divided by the number of participants enrolling in the study
Acceptability Post-intervention: 12 weeks Satisfaction survey
Trial Locations
- Locations (1)
University of Alberta
🇨🇦Edmonton, Alberta, Canada